Tag: U.K.
-
Partnership Developing Faster, Sensitive Covid-19 Test
A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test.
-
Biotech Start-Up Begins Longevity Therapy Work
A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process.
-
Gates Funds Engineered Malaria Mosquito Pilot Test
A developer of genetically altered insects designed to destroy disease-spreading colonies is set to begin pilot tests of its anti-malarial mosquito line.
-
Whole Genome Sequencing Shown to Detect Neuro Disorders
An analysis of genetic database records indicates a class of neurological diseases can be detected by sequencing of a person’s entire genome.
-
Synthetic SARS-CoV-2 Particle Designed for Drug R&D
Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers.
-
Health Breakthrough Research Group Doubles Funding
A not-for-profit organization that sponsors accelerated and high-impact health research worldwide says it gained a new $335 million in funding.
-
Precision Cancer Genomics Company Adds $23M in Early Funds
Biofidelity says its process simplifies detection of genetic indicators in tumors enabling more precise therapies for cancer patients.
-
Start-Up Founders Demonstrate Amputated Tissue Regrowth
Founders of a regenerative medicine company demonstrated a drug delivery device that helps regrow several tissue types on frogs’ amputated limbs.
-
Science/Tech AI Developer Raises $100M in New Funds
A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round.
-
Group Devising Lower Cost Clinical Trials
A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost.